Dr. Kevin Cummings's lab studies how the brain processes and responds to critical conditions like hypoxia, which is low oxygen levels. His team examines how certain brain circuits can affect heart rate and blood pressure recovery in infants and adults, particularly related to areas affected by Sudden Infant Death Syndrome (SIDS) and sleep apnea. Through a combination of rodent studies and human tissue analyses, they aim to uncover new insights that might lead to better prevention strategies for these serious health issues.

Dr. Kiho Lee's lab focuses on improving pigs as important models for both agriculture and human medicine by using advanced genome editing techniques like CRISPR. The research aims to enhance the safety and efficiency of creating genetically engineered pigs, which can help us better understand diseases and improve livestock traits. By developing new methods to quickly analyze these pigs after genetic modifications, the lab strives to make genetically edited pigs more accessible for scientific and agricultural purposes.

Dr. Dana Duren's lab at the University of Missouri-Columbia focuses on improving treatment strategies for craniofacial disorders by utilizing advanced 3D imaging technology. The lab develops new models of craniofacial growth that better reflect real-world conditions based on a diverse dataset of children and young adults. Their work aims to enhance clinical practice by providing evidence-based standards for timing treatments, leading to better outcomes for patients.

Dr. Roman R. Ganta's lab focuses on understanding and combating tick-borne diseases caused by the bacteria Ehrlichia chaffeensis and Anaplasma phagocytophilum. By developing new methods to grow these bacteria without host cells and creating genetic mutations, the lab aims to explore how these pathogens evade immune responses and cause persistent infections. This research has significant implications for public health, especially for high-risk populations affected by these diseases.

Dr. Anthony Griffiths' research lab at the University of Missouri-Columbia focuses on infectious diseases and biocontainment, particularly concerning high-priority pathogens. The lab not only conducts cutting-edge research but also emphasizes the training of future scientists and professionals in dealing with emerging infectious diseases. Using state-of-the-art facilities, the lab aims to develop novel medical countermeasures and improve pandemic preparedness through collaboration and knowledge sharing in the field.

Dr. Shaoping Hou's lab at the University of Missouri-Columbia focuses on understanding how specific dopamine receptors in the spinal cord affect bladder control after spinal cord injuries. They investigate how these receptors can change in response to injury and how stimulating them might help restore urinary function. By using various experimental techniques, the lab aims to develop potential new treatments for urinary disorders that arise from spinal cord injuries.

Dr. David Kline's research lab at the University of Missouri-Columbia focuses on understanding how the balance between excitatory and inhibitory signaling in the brainstem affects breathing and cardiovascular responses, especially during episodes of low oxygen (hypoxia). The lab investigates the role of GABA, an important inhibitory neurotransmitter, in regulating these responses after chronic low-oxygen exposure. By using various advanced techniques, the research aims to uncover mechanisms that could lead to new treatments for breathing-related disorders associated with unstable oxygen levels.

Dr. Christian L. Lorson's lab focuses on developing gene therapies for inherited neurological disorders, particularly Charcot-Marie-Tooth disease and related conditions. The lab works on creating animal models that mimic human diseases to understand the biological processes involved and to test potential therapeutic approaches. Ultimately, the goal is to develop effective treatments that can improve the quality of life for affected individuals.

Dr. Wendy L. Picking's research lab focuses on developing vaccines to prevent infections caused by the antibiotic-resistant bacterium Pseudomonas aeruginosa. The lab explores innovative vaccine formulations that can stimulate an immune response to provide protection against this opportunistic pathogen, particularly in vulnerable populations like the elderly and patients with chronic conditions. By utilizing animal models, the lab assesses the effectiveness of these vaccines to ultimately enhance public health outcomes.

Dr. William D. Picking's lab at the University of Missouri-Columbia focuses on understanding how the Shigella bacterium can cause severe intestinal disease. By studying the structure and function of a specialized mechanism used by the bacteria to inject harmful proteins into human cells, the lab hopes to uncover ways to block this process. This research not only aims to shed light on a major public health issue but also seeks to develop new treatments for infections like shigellosis, particularly in vulnerable populations such as young children.

Dr. Thomas E. Spencer's lab at the University of Missouri-Columbia focuses on understanding the molecular and genetic factors that regulate the development of the uterus, particularly its glands which are crucial for successful pregnancies. The lab investigates how specific genes, particularly FOXA2, influence uterine health and play roles in infertility and uterine diseases. By employing advanced techniques in developmental biology and bioinformatics, the team aims to decipher the biological mechanisms behind uterine development and their implications for fertility and regenerative medicine.